VALERIE SKRELJA M.D. NPI 1124106380

NPI Details

Valerie Skrelja, M.D. is an internal medicine in Berkeley Heights, NJ with 24 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Valerie Skrelja, M.D. NPI is 1124106380. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Graduation Year:2002

The provider's business location address is:

1 DIAMOND HILL RD
SUMMIT MEDICAL GROUP
BERKELEY HEIGHTS, NJ
ZIP 07922-104
Phone: (908) 277-8683
Fax: (908) 608-2378

The NPI 1124106380 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Hemoglobin a1c level (HCPCS:83036)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Bacterial urine culture (HCPCS:87088)
• Bacterial colony count, urine (HCPCS:87086)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Urine microalbumin (protein) level (HCPCS:82043)
• Vitamin d-3 level (HCPCS:82306)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Ferritin (blood protein) level (HCPCS:82728)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)

The enumeration date for this NPI number is 11/2/2006 and was last updated on 7/10/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: